3D technology has allowed heart disease patients to be diagnosed and treated five times faster, UK news
With the help of the new 3D technology, life-threatening coronary heart diseases could be diagnosed and treated five times faster.
The technology turns a CT scan of the heart into a 3D image that doctors can use to diagnose the problem in just 20 minutes, according to NHS England.
Previously, diagnoses required a more invasive and time-consuming angiogram in the hospital.
In the next three years, around 100,000 people will be able to use the new technology called HeartFlow. This could mean they are seen, diagnosed, and treated about five times faster.
Treatment includes surgery, medication, or fitting a stent, while those with less serious medical conditions can receive lifestyle advice or medication to lower cholesterol.
HeartFlow was launched last month and is part of an NHS plan to reduce the number of heart attacks and strokes by 150,000.
Matt Whitty, director of innovation and life sciences at NHS England, said HeartFlow has been a “great success” in clinical trials, helping “tens of thousands of people each year get rapid diagnosis and treatment and ultimately save lives”.
Stephen Powis, NHS Medical Director, said, “The NHS Long-Term Plan aims to reduce strokes, heart attacks and other major culprits, and to ensure that patients benefit from cutting-edge therapies and techniques. HeartFlow is just the latest example of this.”
“By rapidly improving the rate at which we diagnose and treat people with heart disease, we will save thousands of lives and ensure that the NHS delivers not only the most successful vaccination program in healthcare history, but routine services faster than before can provide. ” Pandemic.”
Dr. Derek Connolly, consultant interventional cardiologist at Sandwell and West Birmingham Hospitals NHS Trust, said the technology has “had a significant impact on our hospitals and improved the diagnosis and treatment of the leading cause of death.”
He said, “For every five patients with cardiac CT and HeartFlow analysis, four patients go home knowing they don’t need anything else.
“Half of these patients will take cholesterol tablets because they have early illness and the other half will have normal coronary arteries.”
Professor Sir Nilesh Samani, British Heart Foundation Medical Director, said: “This will benefit patients and the NHS by preventing unnecessary angiograms and providing quick information that will enable patients to find the best course of action for their condition.
“This is especially important at a time when we are grappling with the challenges COVID-19 has created for the normal care of patients with cardiovascular disease.”